A Fontanet
Overview
Explore the profile of A Fontanet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Besombes C, Mbrenga F, Malaka C, Gonofio E, Schaeffer L, Konamna X, et al.
One Health
. 2023 Mar;
16:100523.
PMID: 36950196
Human monkeypox virus is spreading globally, and more information is required about its epidemiological and clinical disease characteristics in endemic countries. We report the investigation of an outbreak in November...
2.
3.
Pomar L, Lambert V, Madec Y, Vouga M, Pomar C, Matheus S, et al.
Ultrasound Obstet Gynecol
. 2019 Nov;
56(5):740-748.
PMID: 31773804
Objectives: To describe placental findings on prenatal ultrasound and anatomopathological examination in women with Zika virus (ZIKV) infection, and to assess their association with congenital ZIKV infection and severe adverse...
4.
El Kassas M, Funk A, Abd El Latif Y, Vasiliu A, Sherief A, Shimakawa Y, et al.
Aliment Pharmacol Ther
. 2018 Jun;
47(11):1564-1566.
PMID: 29878419
No abstract available.
5.
Njouom R, Siffert I, Texier G, Lachenal G, Tejiokem M, Pepin J, et al.
J Viral Hepat
. 2018 Mar;
25(8):959-968.
PMID: 29533500
Cameroon is thought to have one of the highest prevalences of hepatitis C virus (HCV) infection in the world (4.9% among adults). A marked cohort effect exists in several communities...
6.
El Kassas M, Funk A, Salaheldin M, Shimakawa Y, Eltabbakh M, Jean K, et al.
J Viral Hepat
. 2017 Dec;
25(6):623-630.
PMID: 29274197
In Egypt, hepatocellular carcinoma (HCC) is the most common form of cancer and direct-acting antivirals (DAA) are administered on a large scale to patients with chronic HCV infection to reduce...
7.
Dub T, Fontanet A
Rev Neurol (Paris)
. 2017 May;
173(6):361-363.
PMID: 28483386
No abstract available.
8.
Riou J, Ait Ahmed M, Blake A, Vozlinsky S, Brichler S, Eholie S, et al.
J Viral Hepat
. 2015 Oct;
23(4):244-55.
PMID: 26477881
With the introduction of more efficient treatments for hepatitis C virus (HCV), improved epidemiological information is required at the country level to allow evidence-based policymaking for elaboration of national strategies...
9.
Okasha O, Munier A, Delarocque-Astagneau E, El Houssinie M, Rafik M, Bassim H, et al.
East Mediterr Health J
. 2015 Jun;
21(3):199-212.
PMID: 26074220
The objectives of this study were to document the background prevalence and incidence of HCV infection among HCWs in Ain Shams University Hospitals in Cairo and analyse the risk factors...
10.
Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, et al.
J Viral Hepat
. 2014 Jul;
22(3):245-53.
PMID: 25073725
In Egypt, as elsewhere, liver biopsy (LB) remains the gold standard to assess liver fibrosis in chronic hepatitis C (CHC) and is required to decide whether a treatment should be...